Bhagat, S M
Butler, S S
Taylor, J R
McEwen, B S
Strittmatter, S M
Article History
Received: 29 June 2015
Revised: 6 October 2015
Accepted: 14 October 2015
First Online: 1 December 2015
Competing interests
: SMS is a cofounder of Axerion Therapeutics, seeking to develop PrP- and NgR-based therapeutics.